Moneycontrol
HomeNewsBusinessReal EstateCOVID-19 impact | No services for 4 months, Delhi Metro suffers Rs 1,000 crore revenue loss
Trending Topics

COVID-19 impact | No services for 4 months, Delhi Metro suffers Rs 1,000 crore revenue loss

DMRC’s tenants’ businesses, including retail and commercial properties, too, have been hit. Tenants are asking for rent payments to be deferred

July 28, 2020 / 11:11 IST
Story continues below Advertisement

Shut for more than four months following the coronavirus outbreak, the Delhi Metro, the lifeline of the National Capital Region, has lost Rs 1,000 crore in revenue, sources have told Moneycontrol.

“The DMRC (Delhi Metro Rail Corporation) earns Rs 10 crore every day. The total revenue loss so far has been over Rs 1,000 crore ever since the lockdown,” sources said.

Story continues below Advertisement

The country went into lockdown on March 25 to curb the spread of the coronavirus that has known to have infected more than 14.8 lakh people. At least 33,425 people have died while there has been a spike in new cases in recent weeks.

The DMRC, which has 300 trains running on eight lines that make 5,000 trips a day carrying around 1.8 million passengers, hasn’t earned a penny in the past four months. 

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show